Dr. Egerton K. Van Den Berg Jr., MD

Dr. Van Den Berg practices at Orlando Health Medical Group Inc in Eustis, Florida.

Dr. Van Den Berg's NPI, 1821192501, was assigned on September 12, 2006. Dr. Van Den Berg graduated from Duke University School Of Medicine in 1981. Dr. Van Den Berg holds Florida license ME54054.

Dr. Van Den Berg's primary practice is Orlando Health Medical Group Inc, at 3102 Kurt St, Eustis, FL 32726 in Lake County. The practice phone is (321) 841-2452.

Dr. Van Den Berg's primary practice is Orlando Health Medical Group Inc in Eustis, Florida. Dr. Van Den Berg is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Van Den Berg to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Den Berg practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Van Den Berg's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Van Den Berg is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Van Den Berg's licenses on file in 4 states: Florida, Virginia, North Carolina and Texas.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Van Den Berg treats.

CMS data shows 6,596 Medicare services from Dr. Van Den Berg across 27 procedure codes in 2024, for 878 Medicare patients. Medicare paid $408,356 for them.

CMS counts 878 Medicare patients who saw Dr. Van Den Berg in 2024. The largest group is 75 to 84, with 387 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Den Berg's median patient age at 76, with 48% women.

In 2024, Dr. Van Den Berg wrote 7,813 Medicare Part D claims for 934 patients. 88% of them were for generic drugs. CMS names the drug for 7,496 of them, across 59 drugs with 11 or more claims each, at $1,014,330 in total drug cost. In 2023, CMS named 6,042 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Van Den Berg for performance year 2024, reported as part of a group. Dr. Van Den Berg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Van Den Berg as offering telehealth.

Dmand AI links 1 paper to Dr. Van Den Berg.

CMS Open Payments shows 93 general payments to Dr. Van Den Berg from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Cook Medical LLC paid the most, $744.

Dmand AI lists 1 award for Dr. Van Den Berg.

Dr. Van Den Berg graduated from Duke University School Of Medicine in 1981. Dr. Van Den Berg is a member of ACC.

Dr. Van Den Berg is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.